Search

everythinglearnresearchcommunity

for

Search:↓

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Many COVID-19 survivors experience long-term symptoms like fatigue and sleep issues, needing ongoing medical support.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Targeting abnormal lung fluid metabolism could reduce COVID-19 deaths and ventilator use.

Men have higher COVID-19 mortality rates than women due to biological and lifestyle factors.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Genetic differences affect COVID-19 severity and treatment development.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

The microneedle patches effectively treat allergic conjunctivitis with controlled, sustained release of medication.

Solanum nigrum shows promise for treating COVID-19 and its complications, but more research is needed.

Human placenta hydrolysates help treat various diseases and aid healing.

The MATH+ protocol aims to improve COVID-19 outcomes using a combination of specific treatments.

Some alopecia treatments might help treat COVID-19, but more research is needed.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Using existing drugs for new treatments is cost-effective and safer.

TMPRSS2 is crucial for COVID-19 infection and is a potential target for treatment.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

MSC-Exos can aid organ development and offer therapeutic benefits for various conditions.

Placental extracts have antioxidant, anti-inflammatory, and immune-boosting effects, but their exact workings are unclear.

Avicennia marina shows potential to treat Hepatitis C by targeting key proteins.

A new method using human lung cells helps find drugs to block and reduce inflammation from SARS-CoV-2.